Bioinspired gelatin/bioceramic composites loaded with bone morphogenetic protein-2 (BMP-2) promote osteoporotic bone repair
Source abstract
Abstract
There are currently several commercialized products approved by the Food and Drug Administration and the European Medicines Agency based on the use of recombinant human BMP-2 for the treatment of non-unions long fractures and spinal fusion. However, the adverse effects recorded with the use of BMPs suggest the need for drug delivery carriers that allow reducing the required doses and improve their cost-effectiveness. Herein, we have developed a new osteoconductive scaffold that reduces the required doses of BMP-2 for promoting bone regeneration in an osteoporotic defect model. The composite is, in brief, a gelatin-based 3D scaffold reinforced with either calcium sulfate or hydroxyapatite as an inorganic osteoconductive biomaterial. To this end, the organic/inorganic composite systems showed high hydration capacity and good in vitro degradability. The incorporation of 7.5% (m/v) ceramic compounds resulted in scaffolds with stiffer Young modulus (179 and 75 kPa for CaSO4_7 and HA_7, respectively) than bare gelatin hydrogels (48 kPa). Studies with human bone-marrow derived mesenchymal stem cells (hBM-MSCs) revealed that the 3D scaffolds promote cell adhesion and proliferation along with osteogenic differentiation capabilities. Specifically, downregulation of stemness (Nanog, Oct4) genes and upregulation of osteogenic markers (ALP, Col1a1, Fmod) by two fold were observed over 10 days under basal culture conditions. Promisingly, the sustained in vitro release of BMP-2 observed from the porous reinforced scaffolds allowed us to address the critical-sized osteoporotic mice calvarial defects with a relatively low growth factor doses (600 ng BMP-2/scaffold) compared to conventional doses at 2-15 micrograms. Overall, this study demonstrates the promising potential of osteoconductive gelatin/calcium bioceramics composites as osteogenic growth factors delivery carriers for bone-regeneration via ultra-low growth factor doses.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Bone health and osteoporosis research · Bone fractures and treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (61)
Show source-provided references
1. The diagnosis of osteoporosis10.1002/jbmr.5650090802 ↗
2. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures10.1007/s00198-006-0172-4 ↗
3. Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis10.1002/stem.1450 ↗
4. Redundant miR-3077-5p and miR-705 mediate the shift of mesenchymal stem cell lineage commitment to adipocyte in osteoporosis bone marrow10.1038/cddis.2013.130 ↗
5. Low-dose BMP-2 and MSC dual delivery onto coral scaffold for critical-size bone defect regeneration in sheep10.1002/jor.23577 ↗
6. Bone morphogenetic proteins and their antagonists: current and emerging clinical uses10.1111/bph.12724 ↗
7. Key role of the expression of bone morphogenetic proteins in increasing the osteogenic activity of osteoblast-like cells exposed to shock waves and seeded on bioactive glass-ceramic scaffolds for bone tissue engineering10.1177/0885328214541974 ↗
8. Acceleration of bone regeneration in bioactive glass/gelatin composite scaffolds seeded with bone marrow-derived mesenchymal stem cells over-expressing bone morphogenetic protein-710.1016/j.msec.2017.02.097 ↗
9. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned10.1016/j.spinee.2011.04.023 ↗
10. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE® bone Graft)10.1007/s00264-007-0418-6 ↗
11. Rapid healing of a critical-sized bone defect using a collagen-hydroxyapatite scaffold to facilitate low dose, combinatorial growth factor delivery10.1002/term.2934 ↗
12. Constructing multi-component organic/inorganic composite bacterial cellulose-gelatin/hydroxyapatite double-network scaffold platform for stem cell-mediated bone tissue engineering10.1016/j.msec.2017.04.062 ↗
13. Organic-inorganic composites toward biomaterial application
14. Recent advances in gelatin-based therapeutics10.1080/14712598.2019.1610383 ↗
15. Effect of sample pre-contact on the experimental evaluation of cartilage mechanical properties10.1007/s11340-012-9698-x ↗
16. Enzymatic crosslinked gelatin 3D scaffolds for bone tissue engineering10.1016/j.ijpharm.2019.02.043 ↗
17. Osteogenic effect of local, long versus short term BMP-2 delivery from a novel SPU–PLGA–βTCP concentric system in a critical size defect in rats10.1016/j.ejps.2013.06.008 ↗
18. In vivo osteogenic response to different ratios of BMP-2 and VEGF released from a biodegradable porous system10.1002/jbm.a.34183 ↗
19. Bone reservoir: injectable hyaluronic acid hydrogel for minimal invasive bone augmentation10.1016/j.jconrel.2011.02.003 ↗
20. Hydroxyapatite nanowire composited gelatin cryogel with improved mechanical properties and cell migration for bone regeneration10.1088/1748-605X/ab1583 ↗
21. Gelatin- and hydroxyapatite-based cryogels for bone tissue engineering: synthesis, characterization, in vitro and in vivo biocompatibility10.1002/term.1813 ↗
22. In situ bone regeneration enabled by a biodegradable hybrid double-network hydrogel10.1039/C9BM00561G ↗
23. Applications of hydrogels with special physical properties in biomedicine10.3390/polym11091420 ↗
24. Surface-modified silk hydrogel containing hydroxyapatite nanoparticle with hyaluronic acid–dopamine conjugate10.1016/j.ijbiomac.2014.06.052 ↗
25. Review on hydrolytic degradation behavior of biodegradable polymers from controlled drug delivery system
26. Remodelling the extracellular matrix in development and disease10.1038/nrm3904 ↗
27. Calcium mimics the chemotactic effect of conditioned media and is an effective inducer of bone regeneration10.1371/journal.pone.0210301 ↗
28. Matrix elasticity of void-forming hydrogels controls transplanted-stem-cell-mediated bone formation10.1038/nmat4407 ↗
29. Multifunctional scaffolds for facile implantation, spontaneous fixation, and accelerated long bone regeneration in rodents10.1126/scitranslmed.aau7411 ↗
30. Scaffolds and cells for tissue regeneration: different scaffold pore sizes—different cell effects10.1007/s10616-015-9895-4 ↗
31. Controlling the porosity and microarchitecture of hydrogels for tissue engineering10.1089/ten.teb.2009.0639 ↗
32. Combinatorial screening of nanoclay-reinforced hydrogels: a glimpse of the “holy grail” in orthopedic stem cell therapy?10.1021/acsami.8b11436 ↗
33. Strontium-substituted hydroxyapatite grown on graphene oxide nanosheet-reinforced chitosan scaffold to promote bone regeneration10.1039/D0BM00523A ↗
34. Controlled degradation of chitosan-coated strontium-doped calcium sulfate hemihydrate composite cement promotes bone defect repair in osteoporosis rats
35. Calcium sulfate bone cements with nanoscaled silk fibroin as inducer10.1002/jbm.b.34350 ↗
36. Growth factor-eluting technologies for bone tissue engineering10.1007/s13346-015-0233-3 ↗
37. Formulation, colloidal characterization, and in vitro biological effect of BMP-2 loaded PLGA nanoparticles for bone regeneration10.3390/pharmaceutics11080388 ↗
38. Delivering nucleic-acid based nanomedicines on biomaterial scaffolds for orthopedic tissue repair: challenges, Progress and future perspectives10.1002/adma.201505088 ↗
39. The effect of BMP-2 and VEGF loading of gelatin-pectin-BCP scaffolds to enhance osteoblast proliferation10.1002/app.41241 ↗
40. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein10.1016/S0142-9612(03)00337-5 ↗
41. Understanding adsorption-desorption dynamics of BMP-2 on hydroxyapatite (001) surface10.1529/biophysj.106.103168 ↗
42. A review of protein adsorption on bioceramics10.1098/rsfs.2012.0012 ↗
43. Do novel cement-type biomaterials reveal ion reactivity that affects cell viability in vitro?
44. Inflammation, mesenchymal stem cells and bone regeneration10.1007/s00418-018-1643-3 ↗
45. The effect of autologous platelet-rich plasma on bone regeneration by autologous mesenchymal stem cells loaded onto allogeneic cancellous bone granules10.1159/000454915 ↗
46. Stem cell therapies in clinical trials: Progress and challenges10.1016/j.stem.2015.06.007 ↗
47. Evaluation of gelatin microparticles as adherent-substrates for mesenchymal stem cells in a hydrogel composite10.1007/s10439-016-1582-x ↗
48. Evaluation of cell binding to collagen and gelatin: a study of the effect of 2D and 3D architecture and surface chemistry10.1007/s10856-016-5763-9 ↗
49. Quantifying cell confluency by plasmonic nanodot arrays to achieve cultivating consistency10.1021/acssensors.9b00524 ↗
50. The mechanism of mineralization and the role of alkaline phosphatase in health and disease10.1272/jnms.77.4 ↗
51. The expression of marker genes during the differentiation of mesenchymal stromal cells10.17219/acem/68386 ↗
52. Mesenchymal stem cells: cell fate decision to osteoblast or adipocyte and application in osteoporosis treatment10.3390/ijms19020360 ↗
53. Long non-coding RNA GAS5 promotes osteogenic differentiation of bone marrow mesenchymal stem cells by regulating the miR-135a-5p/FOXO1 pathway10.1016/j.mce.2019.110534 ↗
54. Resveratrol improves osteogenic differentiation of senescent bone mesenchymal stem cells through inhibiting endogenous reactive oxygen species production via AMPK activation10.1080/13510002.2019.1658376 ↗
55. Mitogen-activated protein kinase (MAPK)-regulated interactions between osterix and Runx2 are critical for the transcriptional osteogenic program10.1074/jbc.M114.576793 ↗
56. NFAT and osterix cooperatively regulate bone formation10.1038/nm1270 ↗
57. Fucoidan prevents RANKL-stimulated osteoclastogenesis and LPS-induced inflammatory bone loss via regulation of Akt/GSK3β/PTEN/NFATc1 signaling pathway and calcineurin activity10.3390/md17060345 ↗
58. The calcineurin-NFAT pathway and bone: intriguing new findings10.1124/mi.6.4.4 ↗
59. Resveratrol promotes in vitro differentiation of osteoblastic MC3T3-E1 cells via potentiation of the Calcineurin/NFATc1 signaling pathway10.1134/S0006297919060117 ↗
60. Effects of ovariectomy and corticosteroid induced osteoporosis on the osteoinductivity of rhBMP-2 in a segmental long-bone defect model10.1089/ten.tea.2014.0659 ↗
61. In situ gel-forming system for dual BMP-2 and 17β-estradiol controlled release for bone regeneration in osteoporotic rats, drug deliv